supp.fit
All Omega-3 Fatty Acids study protocols

Omega-3 Fatty Acids, Vitamin C, Vitamin E, Copper and Zinc: study protocols

5 study groups took Omega-3 Fatty Acids together with Vitamin C, Vitamin E, Copper and Zinc. These are the doses the studies gave. They are not a recommendation.

Omega-3 Fatty Acids: what the research found →

Dose per serving from research: Omega-3 Fatty Acids

5 study groups in 4 studies say how much Omega-3 Fatty Acids participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mg to 1 g and 1 g to 2.5 g, 40% of 5 study groups each.

Daily doseStudy groups
250 mg to 500 mg
1
500 mg to 1 g
2
1 g to 2.5 g
2

Dose per serving from research: Vitamin C

5 study groups in 4 studies say how much Vitamin C participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 50 mg to 100 mg, 60% of 5 study groups.

Daily doseStudy groups
50 mg to 100 mg
3
100 mg to 250 mg
0
250 mg to 500 mg
2

Dose per serving from research: Copper

5 study groups in 4 studies say how much Copper participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mcg to 500 mcg, 60% of 5 study groups.

Daily doseStudy groups
250 mcg to 500 mcg
3
500 mcg to 1 mg
1
1 mg to 2.5 mg
1

Dose per serving from research: Zinc

5 study groups in 4 studies say how much Zinc participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 2.5 mg to 5 mg, 60% of 5 study groups.

Daily doseStudy groups
2.5 mg to 5 mg
3
5 mg to 10 mg
0
10 mg to 25 mg
1
25 mg to 50 mg
0
50 mg to 100 mg
1

Commonly used together

5 of 5 study groups took Omega-3 Fatty Acids, Vitamin C, Vitamin E, Copper and Zinc with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Vitamin A
4

5 study groups

Study
TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD
2007 · Sham MCS and nutritional supplement · Adults aged 50–90 with dry age-related macular degeneration in at least one eye
300 mg452 mg200 IU1.6 mg69.6 mg24 weeks37
A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction
2013 · Group B (study oral supplement formulation, Brudysec 1.5 g) · Adults aged 23–85 years, both sexes, diagnosed with meibomian gland dysfunction
1.27 g80.1 mg12 mg480 mcg4.8 mg90 days33
Effects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders
2013 · DEDG+S · Adults aged 23–80 years, both sexes, with mild-to-moderate dry eye disorders
845 mg53.4 mg8 mg320 mcg3.2 mg90 days—
Effects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders
2013 · CG+S · Healthy adults aged 23–80 years, both sexes
845 mg53.4 mg8 mg320 mcg3.2 mg90 days—
Omega-3 supplementation combined with anti-vascular endothelial growth factor lowers vitreal levels of vascular endothelial growth factor in wet age-related macular degeneration
2014 · Group 1 (Vitalux plus Omega-3) · Adults with active wet age-related macular degeneration who had previously received anti-VEGF treatment
1.05 g500 mg400 IU1 mg25 mg—10
Omega-3 Fatty Acids, Vitamin C, Vitamin E, Copper and Zinc: study protocols | supp.fit